CYT-IL123 IL12 TNFα

N/A

Report date: 2024/11/21 10:21:22

Base Information

Drug NameCYT-IL123 IL12 TNFα
Drug Alias NameCYT-IL123 IL12 TNFαCYT IL12
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTumor necrosis factor α stimulantsInterleukin-12 stimulantsInterleukin-2 stimulants
TargetsTumor necrosis factor αInterleukin-12Interleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytimmune Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytimmune Sciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A